Insulin Pens Market Size, Share & Trends Analysis Report By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare, Others), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Insulin Pens Market Growth & Trends
The global insulin pens market size is anticipated to reach USD 12.41 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.08% during the forecast period, 2024 to 2030. Key drivers propelling market growth include rising prevalence of diabetes worldwide. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number expected to rise to 643 million by 2030. This escalating figure has significantly fueled the demand for effective and convenient insulin delivery methods, such as insulin pens.
The international agreement aims to stop the rise of diabetes and obesity by 2025. Currently, the majority of the global diabetic population of approximately 422 million resides in lower-income countries, contributing to 1.5 million deaths annually due to type 2 diabetes. Over recent decades, there has been a steady increase in diabetes rates. The latest data from the IDF Diabetes Atlas indicates a global diabetes prevalence rate of 10.5%, with nearly 44.7% of cases remaining undiagnosed. Future forecasts from the IDF suggest that by 2045, the number of adults with diabetes could reach 783 million, or roughly 12.5% of the global population, marking a 46% increase. This uptrend significantly outpaces the anticipated global population growth of 20% for the same timeframe.
Advancements in insulin pen technology, the growing geriatric population, and increasing investments in healthcare infrastructure across various regions have been crucial in market expansion. Furthermore, the shift towards modern insulin delivery devices over traditional syringes and vials has played a pivotal role in market expansion. However, the market faces challenges such as high costs associated with insulin pen therapy and limited reimbursement policies in developing countries. Despite these barriers, ongoing research and development efforts to introduce innovative, cost-effective insulin pens are anticipated to overcome these hurdles.
Global Insulin Pens Market Report Highlights
Insulin Pens Market Growth & Trends
The global insulin pens market size is anticipated to reach USD 12.41 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.08% during the forecast period, 2024 to 2030. Key drivers propelling market growth include rising prevalence of diabetes worldwide. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a number expected to rise to 643 million by 2030. This escalating figure has significantly fueled the demand for effective and convenient insulin delivery methods, such as insulin pens.
The international agreement aims to stop the rise of diabetes and obesity by 2025. Currently, the majority of the global diabetic population of approximately 422 million resides in lower-income countries, contributing to 1.5 million deaths annually due to type 2 diabetes. Over recent decades, there has been a steady increase in diabetes rates. The latest data from the IDF Diabetes Atlas indicates a global diabetes prevalence rate of 10.5%, with nearly 44.7% of cases remaining undiagnosed. Future forecasts from the IDF suggest that by 2045, the number of adults with diabetes could reach 783 million, or roughly 12.5% of the global population, marking a 46% increase. This uptrend significantly outpaces the anticipated global population growth of 20% for the same timeframe.
Advancements in insulin pen technology, the growing geriatric population, and increasing investments in healthcare infrastructure across various regions have been crucial in market expansion. Furthermore, the shift towards modern insulin delivery devices over traditional syringes and vials has played a pivotal role in market expansion. However, the market faces challenges such as high costs associated with insulin pen therapy and limited reimbursement policies in developing countries. Despite these barriers, ongoing research and development efforts to introduce innovative, cost-effective insulin pens are anticipated to overcome these hurdles.
Global Insulin Pens Market Report Highlights
- By type, the insulin pens market is categorized into disposable and reusable insulin pens, with disposable pens holding the largest market share due to their convenience and hygiene benefits
- By end use, the insulin pens market is segmented into hospitals & clinics, homecare, and others. Among these, homecare segment captured the largest market share of 48.21% in 2023
- Furthermore, North America insulin pens market dominated the market by capturing the highest revenue share of 40.73% in 2023 owing to its well-established healthcare infrastructure, high diabetes prevalence, and strong presence of leading market players
- The Asia Pacific region is expected to witness the fastest growth rate (CAGR) of 8.8% during the forecast period, driven by increasing healthcare expenditure, rising diabetes awareness, and improving healthcare facilities in emerging economies such as China and India
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. INSULIN PENS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in the prevalence of diabetes globally
3.2.1.2. Advancements in technology and development of smart insulin pens
3.2.1.3. Growing awareness and education about diabetes management
3.2.1.4. Increasing government initiatives and support to provide accessible and affordable diabetes treatment
3.2.2. Market restraint analysis
3.2.2.1. High cost of smart insulin pens
3.2.2.2. Lack of awareness and education about advanced diabetes management tools
3.2.2.3. Stringent regulatory approvals
3.3. Insulin Pens Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. INSULIN PENS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Insulin Pens Type Market Movement Analysis
4.3. Global Insulin Pens Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Reusable Insulin Pens
4.4.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Disposable Insulin Pens
4.5.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. INSULIN PENS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Insulin Pens End Use Market Movement Analysis
5.3. Global Insulin Pens Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. INSULIN PENS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT , APPLICATION, MODALITY, END USE
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework
6.5.1.4. Reimbursement structure
6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement structure
6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement structure
6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Competitive scenario
6.6.1.3. Regulatory framework
6.6.1.4. Reimbursement structure
6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement structure
6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement structure
6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement structure
6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework
6.6.5.4. Reimbursement structure
6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework
6.6.6.4. Reimbursement structure
6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework
6.6.7.4. Reimbursement structure
6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework
6.6.8.4. Reimbursement structure
6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement structure
6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement structure
6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement structure
6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement structure
6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement structure
6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement structure
6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement structure
6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement structure
6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement structure
6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement structure
6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement structure
6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework
6.9.4.4. Reimbursement structure
6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2023
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. Medtronic Plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Novo Nordisk A/S
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Sanofi
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Eli Lilly and Company
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Ypsomed AG
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Insulet Corporation
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. B. Braun SE
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Owen Mumford Ltd.
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Tandem Diabetes Care, Inc.
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. INSULIN PENS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in the prevalence of diabetes globally
3.2.1.2. Advancements in technology and development of smart insulin pens
3.2.1.3. Growing awareness and education about diabetes management
3.2.1.4. Increasing government initiatives and support to provide accessible and affordable diabetes treatment
3.2.2. Market restraint analysis
3.2.2.1. High cost of smart insulin pens
3.2.2.2. Lack of awareness and education about advanced diabetes management tools
3.2.2.3. Stringent regulatory approvals
3.3. Insulin Pens Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. INSULIN PENS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Insulin Pens Type Market Movement Analysis
4.3. Global Insulin Pens Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Reusable Insulin Pens
4.4.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Disposable Insulin Pens
4.5.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. INSULIN PENS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Insulin Pens End Use Market Movement Analysis
5.3. Global Insulin Pens Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals & Clinics
5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. INSULIN PENS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT , APPLICATION, MODALITY, END USE
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework
6.5.1.4. Reimbursement structure
6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement structure
6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement structure
6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Competitive scenario
6.6.1.3. Regulatory framework
6.6.1.4. Reimbursement structure
6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement structure
6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement structure
6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement structure
6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework
6.6.5.4. Reimbursement structure
6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework
6.6.6.4. Reimbursement structure
6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework
6.6.7.4. Reimbursement structure
6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework
6.6.8.4. Reimbursement structure
6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement structure
6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement structure
6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement structure
6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement structure
6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement structure
6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement structure
6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement structure
6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement structure
6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement structure
6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement structure
6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement structure
6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework
6.9.4.4. Reimbursement structure
6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2023
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. Medtronic Plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Novo Nordisk A/S
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Sanofi
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Eli Lilly and Company
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Ypsomed AG
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Insulet Corporation
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. B. Braun SE
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Owen Mumford Ltd.
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Tandem Diabetes Care, Inc.
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America insulin pens market, By country, 2018 - 2030 (USD Million)
Table 4 North America insulin pens market, By type, 2018 - 2030 (USD Million)
Table 5 North America insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 6 U.S. insulin pens market, By type, 2018 - 2030 (USD Million)
Table 7 U.S. insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 8 Canada insulin pens market, By type, 2018 - 2030 (USD Million)
Table 9 Canada insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 10 Mexico insulin pens market, By type, 2018 - 2030 (USD Million)
Table 11 Mexico insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 12 Europe insulin pens market, By country, 2018 - 2030 (USD Million)
Table 13 Europe insulin pens market, By type, 2018 - 2030 (USD Million)
Table 14 Europe insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 15 UK insulin pens market, By type, 2018 - 2030 (USD Million)
Table 16 UK insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 17 Germany insulin pens market, By type, 2018 - 2030 (USD Million)
Table 18 Germany insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 19 France insulin pens market, By type, 2018 - 2030 (USD Million)
Table 20 France insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 21 Italy insulin pens market, By type, 2018 - 2030 (USD Million)
Table 22 Italy insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 23 Denmark insulin pens market, By type, 2018 - 2030 (USD Million)
Table 24 Denmark insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 25 Sweden insulin pens market, By type, 2018 - 2030 (USD Million)
Table 26 Sweden insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 27 Norway insulin pens market, By type, 2018 - 2030 (USD Million)
Table 28 Norway insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific insulin pens market, By country, 2018 - 2030 (USD Million)
Table 30 Asia Pacific insulin pens market, By type, 2018 - 2030 (USD Million)
Table 31 Asia Pacific insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 32 Japan insulin pens market, By type, 2018 - 2030 (USD Million)
Table 33 Japan insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 34 China insulin pens market, By type, 2018 - 2030 (USD Million)
Table 35 China insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 36 India insulin pens market, By type, 2018 - 2030 (USD Million)
Table 37 India insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 38 Australia insulin pens market, By type, 2018 - 2030 (USD Million)
Table 39 Australia insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 40 South Korea insulin pens market, By type, 2018 - 2030 (USD Million)
Table 41 South Korea insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 42 Thailand insulin pens market, By type, 2018 - 2030 (USD Million)
Table 43 Thailand insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 44 Latin America insulin pens market, By Country, 2018 - 2030 (USD Million)
Table 45 Latin America insulin pens market, By type, 2018 - 2030 (USD Million)
Table 46 Latin America insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 47 Brazil insulin pens market, By type, 2018 - 2030 (USD Million)
Table 48 Brazil insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 49 Argentina insulin pens market, By type, 2018 - 2030 (USD Million)
Table 50 Argentina insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 51 Middle East & Africa insulin pens market, By country, 2018 - 2030 (USD Million)
Table 52 Middle East & Africa insulin pens market, By type, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 54 South Africa insulin pens market, By type, 2018 - 2030 (USD Million)
Table 55 South Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia insulin pens market, By type, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 58 UAE insulin pens market, By type, 2018 - 2030 (USD Million)
Table 59 UAE insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 60 Kuwait insulin pens market, By type, 2018 - 2030 (USD Million)
Table 61 Kuwait insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America insulin pens market, By country, 2018 - 2030 (USD Million)
Table 4 North America insulin pens market, By type, 2018 - 2030 (USD Million)
Table 5 North America insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 6 U.S. insulin pens market, By type, 2018 - 2030 (USD Million)
Table 7 U.S. insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 8 Canada insulin pens market, By type, 2018 - 2030 (USD Million)
Table 9 Canada insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 10 Mexico insulin pens market, By type, 2018 - 2030 (USD Million)
Table 11 Mexico insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 12 Europe insulin pens market, By country, 2018 - 2030 (USD Million)
Table 13 Europe insulin pens market, By type, 2018 - 2030 (USD Million)
Table 14 Europe insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 15 UK insulin pens market, By type, 2018 - 2030 (USD Million)
Table 16 UK insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 17 Germany insulin pens market, By type, 2018 - 2030 (USD Million)
Table 18 Germany insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 19 France insulin pens market, By type, 2018 - 2030 (USD Million)
Table 20 France insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 21 Italy insulin pens market, By type, 2018 - 2030 (USD Million)
Table 22 Italy insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 23 Denmark insulin pens market, By type, 2018 - 2030 (USD Million)
Table 24 Denmark insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 25 Sweden insulin pens market, By type, 2018 - 2030 (USD Million)
Table 26 Sweden insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 27 Norway insulin pens market, By type, 2018 - 2030 (USD Million)
Table 28 Norway insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific insulin pens market, By country, 2018 - 2030 (USD Million)
Table 30 Asia Pacific insulin pens market, By type, 2018 - 2030 (USD Million)
Table 31 Asia Pacific insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 32 Japan insulin pens market, By type, 2018 - 2030 (USD Million)
Table 33 Japan insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 34 China insulin pens market, By type, 2018 - 2030 (USD Million)
Table 35 China insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 36 India insulin pens market, By type, 2018 - 2030 (USD Million)
Table 37 India insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 38 Australia insulin pens market, By type, 2018 - 2030 (USD Million)
Table 39 Australia insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 40 South Korea insulin pens market, By type, 2018 - 2030 (USD Million)
Table 41 South Korea insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 42 Thailand insulin pens market, By type, 2018 - 2030 (USD Million)
Table 43 Thailand insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 44 Latin America insulin pens market, By Country, 2018 - 2030 (USD Million)
Table 45 Latin America insulin pens market, By type, 2018 - 2030 (USD Million)
Table 46 Latin America insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 47 Brazil insulin pens market, By type, 2018 - 2030 (USD Million)
Table 48 Brazil insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 49 Argentina insulin pens market, By type, 2018 - 2030 (USD Million)
Table 50 Argentina insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 51 Middle East & Africa insulin pens market, By country, 2018 - 2030 (USD Million)
Table 52 Middle East & Africa insulin pens market, By type, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 54 South Africa insulin pens market, By type, 2018 - 2030 (USD Million)
Table 55 South Africa insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia insulin pens market, By type, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 58 UAE insulin pens market, By type, 2018 - 2030 (USD Million)
Table 59 UAE insulin pens market, By end-use, 2018 - 2030 (USD Million)
Table 60 Kuwait insulin pens market, By type, 2018 - 2030 (USD Million)
Table 61 Kuwait insulin pens market, By end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Insulin pens market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Industry value chain analysis
Fig. 18 Insulin pens market driver impact
Fig. 19 Insulin pens market restraint impact
Fig. 20 Insulin pens market: Type movement analysis
Fig. 21 Insulin pens market: Type outlook and key takeaways
Fig. 22 Reusable insulin pens market estimates and forecast, 2018 - 2030
Fig. 23 Disposable insulin pens market estimates and forecast, 2018 - 2030
Fig. 24 Insulin pens market: End use movement analysis
Fig. 25 Insulin pens market: End use outlook and key takeaways
Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
Fig. 27 Homecare market estimates and forecast, 2018 - 2030
Fig. 28 Others end users market estimates and forecast, 2018 - 2030
Fig. 29 Global insulin pens market: Regional movement analysis
Fig. 30 Global insulin pens market: Regional outlook and key takeaways
Fig. 31 North America
Fig. 32 North America market estimates and forecasts, 2018 - 2030
Fig. 33 U.S.
Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
Fig. 35 Canada
Fig. 36 Canada market estimates and forecasts, 2018 - 2030
Fig. 37 Mexico
Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
Fig. 39 Europe
Fig. 40 Europe market estimates and forecasts, 2018 - 2030
Fig. 41 UK
Fig. 42 UK market estimates and forecasts, 2018 - 2030
Fig. 43 Germany
Fig. 44 Germany market estimates and forecasts, 2018 - 2030
Fig. 45 France
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy
Fig. 48 Italy market estimates and forecasts, 2018 - 2030
Fig. 49 Spain
Fig. 50 Spain market estimates and forecasts, 2018 - 2030
Fig. 51 Denmark
Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
Fig. 53 Sweden
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway
Fig. 56 Norway market estimates and forecasts, 2018 - 2030
Fig. 57 Asia Pacific
Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 59 China
Fig. 60 China market estimates and forecasts, 2018 - 2030
Fig. 61 Japan
Fig. 62 Japan market estimates and forecasts, 2018 - 2030
Fig. 63 India
Fig. 64 India market estimates and forecasts, 2018 - 2030
Fig. 65 Thailand
Fig. 66 Thailand market estimates and forecasts, 2018 - 2030
Fig. 67 South Korea
Fig. 68 South Korea market estimates and forecasts, 2018 - 2030
Fig. 69 Australia
Fig. 70 Australia market estimates and forecasts, 2018 - 2030
Fig. 71 Latin America
Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
Fig. 73 Brazil
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
Fig. 75 Mexico
Fig. 76 Mexico market estimates and forecasts, 2018 - 2030
Fig. 77 Argentina
Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
Fig. 79 Middle East and Africa
Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 81 South Africa
Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
Fig. 83 Saudi Arabia
Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 85 UAE
Fig. 86 UAE market estimates and forecasts, 2018 - 2030
Fig. 87 Kuwait
Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 89 Market share of key market players- Insulin pens market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Insulin pens market: market outlook
Fig. 14 Parent market outlook
Fig. 15 Related/ancillary market outlook
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Industry value chain analysis
Fig. 18 Insulin pens market driver impact
Fig. 19 Insulin pens market restraint impact
Fig. 20 Insulin pens market: Type movement analysis
Fig. 21 Insulin pens market: Type outlook and key takeaways
Fig. 22 Reusable insulin pens market estimates and forecast, 2018 - 2030
Fig. 23 Disposable insulin pens market estimates and forecast, 2018 - 2030
Fig. 24 Insulin pens market: End use movement analysis
Fig. 25 Insulin pens market: End use outlook and key takeaways
Fig. 26 Hospitals and clinics market estimates and forecast, 2018 - 2030
Fig. 27 Homecare market estimates and forecast, 2018 - 2030
Fig. 28 Others end users market estimates and forecast, 2018 - 2030
Fig. 29 Global insulin pens market: Regional movement analysis
Fig. 30 Global insulin pens market: Regional outlook and key takeaways
Fig. 31 North America
Fig. 32 North America market estimates and forecasts, 2018 - 2030
Fig. 33 U.S.
Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
Fig. 35 Canada
Fig. 36 Canada market estimates and forecasts, 2018 - 2030
Fig. 37 Mexico
Fig. 38 Mexico market estimates and forecasts, 2018 - 2030
Fig. 39 Europe
Fig. 40 Europe market estimates and forecasts, 2018 - 2030
Fig. 41 UK
Fig. 42 UK market estimates and forecasts, 2018 - 2030
Fig. 43 Germany
Fig. 44 Germany market estimates and forecasts, 2018 - 2030
Fig. 45 France
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy
Fig. 48 Italy market estimates and forecasts, 2018 - 2030
Fig. 49 Spain
Fig. 50 Spain market estimates and forecasts, 2018 - 2030
Fig. 51 Denmark
Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
Fig. 53 Sweden
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway
Fig. 56 Norway market estimates and forecasts, 2018 - 2030
Fig. 57 Asia Pacific
Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 59 China
Fig. 60 China market estimates and forecasts, 2018 - 2030
Fig. 61 Japan
Fig. 62 Japan market estimates and forecasts, 2018 - 2030
Fig. 63 India
Fig. 64 India market estimates and forecasts, 2018 - 2030
Fig. 65 Thailand
Fig. 66 Thailand market estimates and forecasts, 2018 - 2030
Fig. 67 South Korea
Fig. 68 South Korea market estimates and forecasts, 2018 - 2030
Fig. 69 Australia
Fig. 70 Australia market estimates and forecasts, 2018 - 2030
Fig. 71 Latin America
Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
Fig. 73 Brazil
Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
Fig. 75 Mexico
Fig. 76 Mexico market estimates and forecasts, 2018 - 2030
Fig. 77 Argentina
Fig. 78 Argentina market estimates and forecasts, 2018 - 2030
Fig. 79 Middle East and Africa
Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 81 South Africa
Fig. 82 South Africa market estimates and forecasts, 2018 - 2030
Fig. 83 Saudi Arabia
Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 85 UAE
Fig. 86 UAE market estimates and forecasts, 2018 - 2030
Fig. 87 Kuwait
Fig. 88 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 89 Market share of key market players- Insulin pens market
